Minerva Neurosciences (NERV) Misses Q4 EPS by 2540c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($25.51), $25.40 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• CrowdStrike Holdings Inc. (CRWD) call put ratio 1 call to 1 put into quarter results
• DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand